The U.S. Food and Drug Administration has approved the first chikungunya vaccine, Ixchiq. The drug has been approved for people of 18 years and above who are at increased risk of exposure to the chikungunya virus which is primarily transmitted to people through the bite of an infected mosquito.
Warning of the potential risk of eye infections that could result in partial vision loss or blindness, federal health officials have recalled more than two dozen eye drops of 26 over-the-counter products due to the potential risk of eye infections that could result in partial vision loss or blindness.
A US Congress committee has raised concern over insufficient foreign drug inspections in India, China. The Department of Defense recently announced that it will begin independently testing the quality and safety of imported generic drugs.
Eli Lilly’s Alzheimer’s drug has shown promise to slow down cognitive and functional decline in people who are in early stages of the disease’s progression, according to results of phase 3 trial. This comes on the heels of Eisai and Biogen’s lecanemab, known by the brand name Leqembi, becoming the first to get US Food and Drug Administration’s (FDA) full approval, earlier this month, to slow down disease progression in adult patients with Alzheimer’s disease.
The US Food and Drug Administration (FDA) has advised consumers not to purchase or eat Everest Garam Masala, Everest Sambhar Masala, and Maggi Masala as Magic spices because they have the potential to be contaminated with Salmonella. The products were manufactured in India and are not labeled for distribution in the United States.
Entrepreneur and Y Combinator Group Partner Surbhi Sarna decodes what it means to be a woman businessperson, especially in female healthcare.
The Bombay High Court on Wednesday quashed the Maharashtra FDA’s order cancelling the licence of pharma giant Johnson & Johnson to manufacture its baby powder from the Mulund plant.
A US Congressional panel released a new report detailing efforts by the Trump administration to politicize federal response to the Covid-19 pandemic. The House Select Subcommittee on the Coronavirus Crisis accused the White House under former US President Donald Trump of undermining “public health to benefit the former president’s political goals”.
